# Optimization of Beta-lactam Dosing in Critically Ill Patients With Cystatin C (OPTIMIZE-GNI)

> clinical trial · VERIFIED · 2026-07-31

Status: COMPLETED · Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) · Condition: Bacterial Infection

- Company: National Institute of Allergy and Infectious Diseases (NIAID)
- Sector: Bacterial Infection
- Primary source: https://clinicaltrials.gov/study/NCT06709521

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.